CHI Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$13.5M Hold
3,414,468
5.35% 6
2023
Q2
$8.72M Buy
3,414,468
+668,203
+24% +$2.73M 2.65% 9
2023
Q1
$12.4M Sell
2,746,265
-727,101
-21% -$3.8M 3.3% 6
2022
Q4
$14.3M Buy
3,473,366
+58,218
+2% +$199K 3.82% 6
2022
Q3
$10.9M Buy
3,415,148
+1,900,000
+125% +$4.76M 2.94% 7
2022
Q2
$2.97M Hold
1,515,148
1.14% 19
2022
Q1
$6.14M Hold
1,515,148
2.61% 8
2021
Q4
$16.3M Hold
1,515,148
5.43% 5
2021
Q3
$17.5M Hold
1,515,148
5.1% 7
2021
Q2
$14.9M Hold
1,515,148
3.46% 9
2021
Q1
$22.1M Hold
1,515,148
4.43% 9
2020
Q4
$32.4M Hold
1,515,148
9.14% 4
2020
Q3
$23M Hold
1,515,148
8.18% 4
2020
Q2
$19.5M Buy
+1,515,148
New +$17.6M 7.6% 5

Other funds holding LRMR